NCT01683968

Brief Summary

This study is designed to investigate the presence and absence of abnormal heart muscle contractions during sickle cell crises. You will be asked to do echocardiography during and after your admission to the hospital. We will compare tow pictures and study the differences.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
216

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2012

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2012

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

September 8, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 12, 2012

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
Last Updated

September 13, 2012

Status Verified

September 1, 2012

Enrollment Period

3.1 years

First QC Date

September 8, 2012

Last Update Submit

September 12, 2012

Conditions

Sickle Cell

Study Arms (1)

Sickle cell

Patient who are admitted with sickle cell crises

Eligibility Criteria

Age14 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patient admitted to the hospital with vaso-occlusive crisis

You may qualify if:

  • Patients older than 18 years
  • Diagnosis of acute vaso-occlusive crisis due to sickle cell disease.
  • Informed consent

You may not qualify if:

  • Congenital heart disease
  • Long standing hypertension

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

King Abdulaziz Hospital

Al-Ahsa, EP, 31982, Saudi Arabia

RECRUITING

Central Study Contacts

Dr Abdulsalam M Alaithan, MD

CONTACT

96635910000aithana@ngha.med.sa

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
CONSULTANT INTENSIVEST AND PULMONOLOGIST

Study Record Dates

First Submitted

September 8, 2012

First Posted

September 12, 2012

Study Start

September 1, 2012

Primary Completion

October 1, 2015

Study Completion

October 1, 2015

Last Updated

September 13, 2012

Record last verified: 2012-09

Locations

SA(1)